FIELD: medicine, pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutical agent containing factor VII or factor VII-related polypeptide and factor VIII or factor VIII-related polypeptide. Disclosed are application of factor VII or factor VII-related polypeptide and factor VIII or factor VIII-related polypeptide in production of drug, kit for episodic bleeding treatment, as well as methods for prophylaxis and treatment of episodic bleeding in subject.
EFFECT: accelerated coagulation of FVIII-deficit plasma.
43 cl, 1 tbl, 2 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INTEGRAL APPLICATION OF FACTOR VII POLYPEPTIDES AND FACTOR IX POLYPEPTIDES | 2002 |
|
RU2292909C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING FACTOR VII POLYPEPTIDES AND FACTOR XI POLYPEPTIDES | 2002 |
|
RU2298416C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VII POLYPEPTIDES AND PAI-1 POLYPEPTIDES | 2002 |
|
RU2304980C2 |
| LIQUID COMPOSITION OF FACTOR VII POLYPEPTIDES | 2002 |
|
RU2357751C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VIIA AND FACTOR XIII | 2001 |
|
RU2272648C2 |
| DERIVATIVES OF FACTOR OF VII BLOOD COAGULATION | 2002 |
|
RU2338752C2 |
| POLYPEPTIDE OF VII HUMAN COAGULATION FACTOR, PRODUCTION AND APPLICATION | 2002 |
|
RU2325401C2 |
| MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE | 2007 |
|
RU2466141C2 |
| FACTOR VII CHIMERIC MOLECULES | 2010 |
|
RU2563231C2 |
| LIQUID WATER PHARMACEUTICAL COMPOSITION CONTAINING FACTOR VII POLYPEPTIDE | 2004 |
|
RU2388460C2 |
